X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7122) 7122
Book Review (880) 880
Publication (411) 411
Newsletter (57) 57
Magazine Article (49) 49
Book Chapter (20) 20
Conference Proceeding (13) 13
Trade Publication Article (3) 3
Newspaper Article (2) 2
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6102) 6102
humans (5448) 5448
doxycycline - therapeutic use (4370) 4370
male (3234) 3234
female (2944) 2944
anti-bacterial agents - therapeutic use (2688) 2688
doxycycline (2639) 2639
adult (2163) 2163
animals (1950) 1950
middle aged (1698) 1698
doxycycline - administration & dosage (998) 998
treatment outcome (998) 998
aged (938) 938
doxycycline - pharmacology (933) 933
infectious diseases (932) 932
adolescent (810) 810
abridged index medicus (694) 694
pharmacology & pharmacy (670) 670
microbiology (657) 657
antibiotics (652) 652
mice (641) 641
anti-bacterial agents - administration & dosage (595) 595
drug therapy, combination (571) 571
medicine, general & internal (476) 476
child (464) 464
health aspects (464) 464
dentistry (457) 457
anti-bacterial agents - pharmacology (450) 450
infections (435) 435
diagnosis (431) 431
immunology (419) 419
research (409) 409
therapy (408) 408
drug therapy (396) 396
time factors (384) 384
analysis (375) 375
care and treatment (372) 372
tetracycline (370) 370
administration, oral (357) 357
doxycycline - adverse effects (354) 354
diagnosis, differential (350) 350
disease (350) 350
tetracyclines (346) 346
dermatology (342) 342
infection (338) 338
follow-up studies (325) 325
rats (324) 324
dentistry, oral surgery & medicine (318) 318
brucellosis - drug therapy (312) 312
rifampin - therapeutic use (304) 304
risk factors (304) 304
expression (295) 295
chlamydia infections - drug therapy (285) 285
microbial sensitivity tests (281) 281
retrospective studies (272) 272
disease models, animal (271) 271
minocycline (263) 263
prospective studies (261) 261
double-blind method (255) 255
young adult (253) 253
veterinary sciences (252) 252
azithromycin (250) 250
research article (244) 244
in-vitro (241) 241
dogs (237) 237
gene expression (237) 237
pregnancy (235) 235
medicine (234) 234
azithromycin - therapeutic use (232) 232
anti-infective agents - therapeutic use (231) 231
surgery (228) 228
article (226) 226
lyme disease - drug therapy (226) 226
bacteria (224) 224
child, preschool (223) 223
multidisciplinary sciences (219) 219
anti-bacterial agents - adverse effects (217) 217
oncology (216) 216
matrix metalloproteinases (215) 215
tetracycline - therapeutic use (212) 212
inflammation (210) 210
travel (210) 210
dosage and administration (208) 208
dose-response relationship, drug (207) 207
aged, 80 and over (206) 206
antibodies, bacterial - blood (204) 204
acute disease (203) 203
polymerase chain reaction (201) 201
efficacy (198) 198
clinical trials as topic (197) 197
drugs (193) 193
chronic disease (192) 192
antimalarials - therapeutic use (191) 191
medicine, research & experimental (189) 189
cancer (188) 188
medicine & public health (186) 186
proteins (186) 186
inhibition (184) 184
recurrence (184) 184
chlamydia trachomatis (180) 180
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6458) 6458
French (200) 200
German (190) 190
Spanish (104) 104
Russian (62) 62
Dutch (38) 38
Japanese (36) 36
Polish (28) 28
Italian (24) 24
Turkish (19) 19
Hungarian (14) 14
Chinese (12) 12
Norwegian (12) 12
Finnish (10) 10
Swedish (9) 9
Czech (7) 7
Danish (7) 7
Portuguese (5) 5
Hebrew (4) 4
Bulgarian (2) 2
Korean (2) 2
Ukrainian (2) 2
Croatian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Medicine, ISSN 1549-1277, 12/2007, Volume 4, Issue 12, pp. 1872 - 1878
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 11/2011, Volume 106, Issue 11, pp. 1970 - 1975
OBJECTIVES: Resistance to standard Helicobacter pylori (HP) treatment regimens has led to unsatisfactory cure rates in HP-infected patients. This study was... 
UNITED-STATES | HELIOBACTER-PYLORI | RISK-FACTORS | METAANALYSIS | MANAGEMENT | EFFICACY | REGIMEN | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | ANTIMICROBIAL RESISTANCE | CONSENSUS REPORT | Levofloxacin | Recurrence | Prospective Studies | Humans | Middle Aged | Ofloxacin - therapeutic use | Helicobacter Infections - complications | Male | Thiazoles - administration & dosage | Thiazoles - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Helicobacter pylori | Proton Pump Inhibitors - administration & dosage | 2-Pyridinylmethylsulfinylbenzimidazoles - therapeutic use | Helicobacter Infections - drug therapy | Ofloxacin - administration & dosage | Adult | Female | Drug Therapy, Combination | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Doxycycline - therapeutic use | Omeprazole - administration & dosage | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Anti-Ulcer Agents - administration & dosage | Amoxicillin - therapeutic use | Intention to Treat Analysis | Anti-Bacterial Agents - administration & dosage | Lansoprazole | Protons | Clarithromycin | Clinical trials | Gastritis | Infection | Omeprazole | Side effects | Antibiotics | peptic ulcers | Amoxicillin | Doxycycline | Endoscopy | Feces | Index Medicus | Stomach
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2009, Volume 180, Issue 9, pp. 896 - 902
Rationale: The optimal therapeutic regimen and duration of treatment for Mycobacterium abscessus lung disease is not well established. Objectives: To assess... 
Treatment outcome | Lung diseases | Mycobacterium abscessus | Atypical mycobacteria | lung diseases | DIAGNOSIS | INFECTIONS | NONTUBERCULOUS MYCOBACTERIA | CLARITHROMYCIN RESISTANCE | treatment outcome | CHELONAE | atypical mycobacteria | RAPIDLY GROWING MYCOBACTERIA | IN-VITRO | RESPIRATORY SYSTEM | MULTIDRUG-RESISTANT TUBERCULOSIS | SP-NOV | NODULAR BRONCHIECTASIS | CRITICAL CARE MEDICINE | Sputum - microbiology | Lung - microbiology | Cefoxitin - therapeutic use | Lung Diseases - microbiology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Lung Diseases - drug therapy | Anti-Bacterial Agents - therapeutic use | Sputum - drug effects | Liver - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Neutropenia - chemically induced | Chemical and Drug Induced Liver Injury - etiology | Doxycycline - adverse effects | Ciprofloxacin - adverse effects | Nontuberculous Mycobacteria - drug effects | Clarithromycin - adverse effects | Doxycycline - therapeutic use | Ciprofloxacin - therapeutic use | Anti-Infective Agents - therapeutic use | Treatment Outcome | Clarithromycin - therapeutic use | Thrombocytopenia - chemically induced | Nontuberculous Mycobacteria - isolation & purification | Amikacin - adverse effects | Amikacin - therapeutic use | Lung - drug effects | Cefoxitin - adverse effects | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Endodontics, ISSN 0099-2399, 2014, Volume 40, Issue 6, pp. 845 - 848
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 855 - 863
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
SOFT-TISSUE INFECTIONS | STREPTOCOCCUS-PYOGENES | DOSE PHARMACOKINETICS | ANTIBACTERIAL ACTIVITY | MOUSE MODEL | ECONOMIC OUTCOMES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | LENGTH-OF-STAY | MURINE THIGH INFECTION | COMPLICATED SKIN | TRIMETHOPRIM-SULFAMETHOXAZOLE | Linezolid | Skin - microbiology | Mupirocin - administration & dosage | Male | Luminescent Measurements | Mupirocin - therapeutic use | Oxazolidinones - administration & dosage | Skin - injuries | Oxazolidinones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Staphylococcal Skin Infections - drug therapy | Acetamides - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Clindamycin - administration & dosage | Community-Acquired Infections - drug therapy | Diabetes Mellitus, Type 2 | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Wound Healing - drug effects | Daptomycin - therapeutic use | Disease Models, Animal | Staphylococcal Infections - drug therapy | Vancomycin - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Administration, Oral | Doxycycline - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Mice, Inbred C57BL | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Bacterial Load | Clindamycin - therapeutic use | Animals | Soft Tissue Infections - microbiology | Vancomycin - therapeutic use | Mice | Administration, Topical | Anti-Bacterial Agents - administration & dosage | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Daptomycin - administration & dosage | Acetamides - administration & dosage | Index Medicus | Animal models | Bioluminescence | Intravenous administration | Image processing | Clindamycin | Vancomycin | Cellulitis | Drug resistance | Polyethylene glycol | Surgery | daptomycin | Ointments | Wound infection | Wound healing | Diabetes mellitus | Antimicrobial agents | Folliculitis | Mupirocin | imaging | Soft tissues | Drainage | Photography | Antibiotics | trimethoprim-sulfamethoxazole | Ulcers | Doxycycline | Impetigo | Skin | Experimental Therapeutics
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, pp. e49642 - e49642
Background: Despite the importance of the renin-angiotensin (Ang) system in abdominal aortic aneurysm (AAA) pathogenesis, strategies targeting this system to... 
INDUCED ATHEROSCLEROSIS | ANGIOGENESIS | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | MONOCYTE CHEMOATTRACTANT PROTEIN-1 | CONVERTING ENZYME-INHIBITORS | TYPE-1 RECEPTOR | EXPRESSION | RAT MODEL | ENDOTHELIAL GROWTH-FACTOR | SIMVASTATIN SUPPRESSES | Aortic Aneurysm, Abdominal - prevention & control | Benzoates - therapeutic use | Fatty Acids, Monounsaturated - pharmacology | Tetrazoles - pharmacology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Male | Angiotensin II Type 1 Receptor Blockers - pharmacology | Biphenyl Compounds - therapeutic use | Fatty Acids, Monounsaturated - therapeutic use | Biphenyl Compounds - pharmacology | Indoles - pharmacology | Benzimidazoles - therapeutic use | Aortic Aneurysm, Abdominal - drug therapy | Doxycycline - therapeutic use | Mice, Inbred C57BL | Sulfonamides - pharmacology | Mice, Knockout | Animals | Sulfonamides - therapeutic use | Apolipoproteins E - genetics | Benzoates - pharmacology | Benzimidazoles - pharmacology | Doxycycline - pharmacology | Indoles - therapeutic use | Tetrazoles - therapeutic use | Mice | Endothelin | Proteases | Angiotensin | Aneurysms | Antihypertensive drugs | Development and progression | Comparative analysis | Gene expression | Animal models | Pathogenesis | Aneurysm | Smooth muscle | Systematic review | Macrophages | Infusion | Ultrasonic imaging | Histopathology | Fluvastatin | Renin | Apolipoprotein E | Rodents | Atherosclerosis | Aorta | Elastase | Pancreas | Angiotensin II | Dissection | Enlargement | Pancreatic elastase | Vascular surgery | Effectiveness | Mortality | Muscles | Inflammation | Apolipoproteins | Disease control | Constraining | Abdomen | Medicine | Coronary vessels | Doxycycline | Infiltration | In vivo methods and tests | Index Medicus
Journal Article